Meningitis Vaccine

Meningitis Vaccine


  Meninges-en.svg

Meningitis is an acute inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges. The inflammation may be caused by infection with viruses, bacteria, or other microorganisms, and less commonly by certain drugs. Meningococcal vaccines protect against most types of meningococcal disease, although they do not prevent all cases. Two kinds of vaccines have been developed to protect against Neisseria meningitides: meningococcal polysaccharide vaccine, and meningococcal conjugate vaccine. Meningococcal vaccines exist against groups A, B, C, W135 and Y. In countries where the vaccine for meningococcal group C was introduced, cases by this pathogen have decreased substantially. A quadrivalent vaccine now exists, which combines all four vaccines.

In SOBHAN, Meningitis quadrivalent (ACWY) is in the final steps of pilot production, while a unique production site with first class facilities, QA and QC systems is under construction adhering to FDA and EMA regulations.